1. Home
  2. EYPT vs NBR Comparison

EYPT vs NBR Comparison

Compare EYPT & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • NBR
  • Stock Information
  • Founded
  • EYPT 1987
  • NBR 1952
  • Country
  • EYPT United States
  • NBR Bermuda
  • Employees
  • EYPT N/A
  • NBR N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • NBR Oil & Gas Production
  • Sector
  • EYPT Industrials
  • NBR Energy
  • Exchange
  • EYPT Nasdaq
  • NBR Nasdaq
  • Market Cap
  • EYPT 594.5M
  • NBR 523.7M
  • IPO Year
  • EYPT 2005
  • NBR N/A
  • Fundamental
  • Price
  • EYPT $7.48
  • NBR $66.51
  • Analyst Decision
  • EYPT Strong Buy
  • NBR Hold
  • Analyst Count
  • EYPT 8
  • NBR 7
  • Target Price
  • EYPT $25.71
  • NBR $97.00
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • NBR 328.8K
  • Earning Date
  • EYPT 03-06-2025
  • NBR 02-12-2025
  • Dividend Yield
  • EYPT N/A
  • NBR N/A
  • EPS Growth
  • EYPT N/A
  • NBR N/A
  • EPS
  • EYPT N/A
  • NBR N/A
  • Revenue
  • EYPT $45,713,000.00
  • NBR $2,926,108,000.00
  • Revenue This Year
  • EYPT N/A
  • NBR N/A
  • Revenue Next Year
  • EYPT N/A
  • NBR $13.73
  • P/E Ratio
  • EYPT N/A
  • NBR N/A
  • Revenue Growth
  • EYPT 7.50
  • NBR N/A
  • 52 Week Low
  • EYPT $6.90
  • NBR $50.15
  • 52 Week High
  • EYPT $30.99
  • NBR $105.96
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • NBR 57.69
  • Support Level
  • EYPT $7.15
  • NBR $61.92
  • Resistance Level
  • EYPT $8.25
  • NBR $68.66
  • Average True Range (ATR)
  • EYPT 0.66
  • NBR 3.14
  • MACD
  • EYPT -0.01
  • NBR 1.58
  • Stochastic Oscillator
  • EYPT 22.01
  • NBR 85.88

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and innovative technologies. It has operations in over 15 countries, 291 actively marketed rigs for land-based drilling operations and 28 actively marketed rigs for offshore platform drilling operations in the United States and multiple international markets. The company has five reportable segments: U.S. Drilling, Canada Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

Share on Social Networks: